Vagus nerve stimulation for refractory status epilepticus

Area of Science:

• Neurology
• Pediatric Epilepsy
• Neurostimulation

Background:

• Refractory non-convulsive status epilepticus (SE) presents significant treatment challenges in pediatric patients.
• Previous treatments for this patient included thiopental-induced coma, highlighting the severity and resistance to standard therapies.

Purpose of the Study:

• To report the long-term follow-up of a pediatric patient with refractory non-convulsive SE treated with vagus nerve stimulation (VNS).
• To evaluate the acute and sustained efficacy of VNS in seizure control and medication management.

Main Methods:

• A 7-year-old girl with a history of neurological complications and epilepsy presented with refractory non-convulsive SE.
• Vagus nerve stimulator (VNS) implantation was performed after prolonged coma induced by thiopental.
• Patient's response was monitored via electroencephalography (EEG) and clinical seizure frequency.

Main Results:

• VNS implantation facilitated the successful withdrawal of thiopental-induced coma within three days.
• EEG normalization was observed one week after initiating VNS therapy.
• The patient remained seizure-free for 13 months post-implantation, with partial tapering of anti-epileptic drugs (AEDs).

Conclusions:

• Vagus nerve stimulation (VNS) demonstrated an acute abortive effect and sustained long-term seizure reduction in a pediatric case of refractory non-convulsive SE.
• VNS offers a promising therapeutic option for managing severe, treatment-resistant epilepsy in children.
• This case underscores the potential of VNS as an adjunctive therapy for improving seizure control and quality of life in pediatric epilepsy patients.